Sternal Closure Systems Market to Reach $2,345.2 Million by 2027; Increasing Number of Cardiac Deaths to Stoke Demand

The global sternal closure systems market size is expected to showcase significant growth by reaching USD 2,345.2 million by 2027. This growth is attributable to the increasing number of cardiac deaths that is likely to drive the adoption of advanced sternal closure devices globally. Fortune Business Insights in its latest report, titled, “Sternal Closure Systems Market Size, Share & Covid-19 Impact Analysis, By Product (Closure Devices and Bone Cement), By Procedure (Median Sternotomy, Bilateral Sternotomy, and Hemisternotomy) By Material (Stainless Steel, Titanium, and PEEK) and Regional Forecast, 2020-2027.”, mentions that the market stood at USD 2,216.1 million in 2019 and is projected to exhibit a CAGR of 5.6% between 2020 and 2027.

Zimmer Biomet Consolidates Position with Worth USD 250 Million A&E Medical Buyout

In December 2020, Zimmer Biomet Holdings, Inc. announced the acquisition of A&E Medical that has a comprehensive portfolio of advanced sternal closure devices. The acquisition, which is worth USD 250 million, is expected to expand Zimmer Biomet’s Dental, Spine, & Cranio maxillofacial and Thoracic (CMFT) product segment.

The deal involved the transaction of USD 150 million in cash and the remaining USD 100 million by the end of 2021. Zimmer estimates the business to rise at a single-digit percentage every year and is likely to expand its product portfolio to cater to the unmet patient and surgical needs.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/sternal-closure-systems-market-102039

Increasing Number of Cardiac Deaths to Propel Market Growth

According to the World Health Organization (WHO), around 655,000 American deaths are reported due to cardiac failure every year. Additionally, heart ailments are the leading cause of death in the United States. The increasing number of deaths caused due to cardiovascular diseases is expected to drive the demand for advanced sternal closure devices to stabilize and fix the sternum after sternotomy. Moreover, the growing number of open-heart surgeries are anticipated to contribute to the global market growth during the forecast period.

Major Companies Focus on Product Launches to Amplify Their Market Positions

The global sternal closure systems market comprises small, medium, and large companies striving to maintain their presence by introducing innovative sternal closure devices. Moreover, other key players are investing in R&D activities to cater to the growing demand for advanced orthopedic devices that are likely to bode well for the growth of the market during the forecast period.  

Industry Development:

• March 2019 - Stryker announced the approval for its Sternal Plate Systems by the U.S. FDA that aids in sternal fixation and closure after sternotomy or sternum fracture. The approval is expected to boost its position in the highly competitive global marketplace.

List of the Companies Profiled in the Global Market for Sternal Closure:

• Johnson and Johnson Services Inc. (U.S)


• Zimmer Biomet (U.S)


• KLS Martin Group (Germany)


• B Braun Medical (Germany)


• Stryker (U.S)


• Jace Medical, LLC (U.S)


• Kinamed Incorporated (U.S)


• Idear S.R.L (Argentina)


• Acute Innovations (U.S)


• Other Predominant Players

Further Report Findings:

• North America stood at USD 1,017.0 million in 2019 and is expected to hold the highest position in the global sternal closure systems market during the forecast period. This is attributable to the increasing prevalence of cardiovascular diseases that propel the demand for innovative sternal closure devices in the region between 2020 and 2027.


• The market in Asia-Pacific is anticipated to showcase exponential growth backed by the increasing development rate in the public healthcare sector and the growing demand for joint implants in the region.


• The titanium segment, based on material, is expected to gain momentum in the forthcoming years. This is ascribable to factors such as increasing demand for titanium-based sternal closure devices due to their higher biocompatibility across the globe.

 Table of Segmentation: